Business Solutions
Brand Acquisition Due Diligence
A regulatory due diligence review of a target brand's portfolio before you buy or invest: are the safety reports valid, is there a Responsible Person, are notifications live, and what does remediation cost?
A cosmetic brand is only worth what its compliance can withstand. An acquisition or investment that looks sound on revenue can carry a portfolio of products that are not lawfully on the market, and that liability transfers with the deal.
What the review covers
Our Regulatory Due Diligence Review, at £275, examines a target’s portfolio against the questions that decide real value: are the Cosmetic Product Safety Reports valid and current, is there a properly designated Responsible Person, are the notifications live in every market claimed, do the labels and claims comply, and are there ingredient time-bombs, substances facing imminent restriction that will force reformulation. The output tells a buyer what they are actually acquiring and what it will cost to put right.
From diligence to holding the floor
Where a deal proceeds, the review feeds straight into taking the portfolio on. A change in the owning entity is not invisible to the regulator: the notifications have to be updated under Article 13 and the Responsible Person re-designated, so a portfolio whose notifications still name the seller, or whose Responsible Person ceases to exist on completion, is non-compliant from the new owner’s first day. The £275 review is credited against a subsequent Responsible Person engagement, so the diligence work is not money spent twice. For an investor or acquirer, knowing the remediation cost before completion is the difference between a priced risk and a nasty surprise.
Relevant services
CPSR
From £70 · 2 to 3 days
The Cosmetic Product Safety Report is the safety assessment required under Article 10 and Annex I of Regulation (EC) No 1223/2009 before a cosmetic product may be placed on the UK or EU market. Prepared and signed by a qualified safety assessor.
Learn more →Responsible Person
From £149 · per product, per year
Oxford Biosciences acts as your Responsible Person in the UK and the EU under a single quality management system, holding the regulatory obligation: PIF maintenance, SCPN and CPNP notification, labelling oversight, and cosmetovigilance.
Learn more →Global Markets
From £149
Cosmetic regulatory documentation for markets beyond the EU and UK: Canada, Australia, New Zealand, ASEAN, the GCC and Latin America, prepared from the same evidence base by the assessor who signs our CPSRs.
Learn more →Frequently asked questions
What is a CPSR?
A Cosmetic Product Safety Report (CPSR) is the safety assessment required by Article 10 and Annex I of Regulation (EC) No 1223/2009 before a cosmetic product is placed on the UK or EU market. Annex I sets out two parts: Part A, the cosmetic product safety information (composition, physico-chemical and microbiological characteristics, stability, exposure and the toxicological profile of each substance), and Part B, the safety assessment, in which a qualified assessor states and reasons the conclusion on safety. It is the pivotal scientific document held within the Product Information File.
What is a Responsible Person?
Every cosmetic product placed on the EU or UK market must have a Responsible Person established within that jurisdiction. Under Articles 4 and 5 of Regulation (EC) No 1223/2009, the Responsible Person is the legal entity that holds the regulatory obligation for the product: it maintains the Product Information File, makes the CPNP or SCPN notification, oversees labelling, and handles cosmetovigilance and contact with the competent authority. It is not simply a postal address. Oxford Biosciences acts as Responsible Person in both the UK and the EU under a single quality management system.
Which international markets does Oxford Biosciences cover?
Beyond the EU and UK, Oxford Biosciences prepares the United States MoCRA Toxicological Risk Assessment (£395), the Canadian Health Canada Cosmetic Notification (£395), the Australian AICIS Compliance Statement (£149), the New Zealand EPA Group Standard Compliance Statement (£179), and the ASEAN Cosmetic Directive Documentation Package (£249), with GCC and Latin American markets (Brazil, Mexico, Argentina and Chile) quoted on application. Where markets share an evidence base, a single Product Information File carries the jurisdiction-specific annexes rather than requiring a separate dossier for each.